E. Blind

1.7k citations
48 papers · 1.1k · 1 hit paper · h-index 15

Impact in

Papers in

    • Bone health and treatments 26
    • Metabolism, Diabetes, and Cancer 8
    • Protein Kinase Regulation and GTPase Signaling 6

E. Blind

48 papers receiving 1.1k citations

E. Blind's Hit Papers

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment 2014 · 375 citations
3750+4+8Years since publication100200300

Peers

E. Blind
Comparison fields: 5 of 76
  • Nephrology 213
  • Endocrinology, Diabetes and Metabolism 430
  • Oncology 347
  • Orthopedics and Sports Medicine 98
  • Molecular Biology 360
Replace Leonid Katz with:
Leonid Katz United States
Yuichi Takashi Japan
Philipp Rein Austria
James W. Edmondson United States
Denise M. Sadlier Ireland
Maya Ish‐Shalom Israel
Henrik Reinhard Denmark
Edith Hamilton United Kingdom
Giovanna Castoldi Italy
J Minamikawa Japan
E. Blind relative to Leonid Katz United States Leonid Katz's profile →
Citations per field
00.5×1.5×1.9×
Leonid Katz · 1×
Citations per year

Countries citing papers authored by E. Blind

Since Specialization
Citations

This map shows the geographic impact of E. Blind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Blind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Blind more than expected).

Fields of papers citing papers by E. Blind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Blind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Blind. The network helps show where E. Blind may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Blind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Blind Line = papers co-authored together E. Blind links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
Hit paper breakdown →
2014375
2 198891
3 199359
4 199458
5 199548
6 201040
7 198738
8 199238
9 199637
10 199232
11 200128
12 199227
13 199027
14 201821
15 199215
16 199214
17 200214
18 200713
19
Structure and function of the receptor for parathyroid hormone and parathyroid hormone-related protein.
199312
20 199311

About E. Blind

E. Blind is a scholar working on Oncology, Molecular Biology, Nephrology, Endocrinology, Diabetes and Metabolism and Physiology, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bone health and treatments (26 papers), Parathyroid Disorders and Treatments (14 papers), Metabolism, Diabetes, and Cancer (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Neuropeptides and Animal Physiology (5 papers), Thyroid Disorders and Treatments (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and Genetic Syndromes and Imprinting (4 papers). The work is most often cited by research in Nephrology (213 citations), Endocrinology, Diabetes and Metabolism (430 citations), Oncology (347 citations), Orthopedics and Sports Medicine (98 citations) and Molecular Biology (360 citations). E. Blind has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Kristina Dunder, B. Timothy Hummer, Curtis J. Rosebraugh, T. Bourcier, Amy Egan, Friedhelm Raue, H. Schmidt‐Gayk, Robert A. Nissenson, R. Ziegler and Tom Bambino. Their work appears in journals such as Clinical Chemistry, The Journal of Clinical Endocrinology & Metabolism, Bone, European Journal of Endocrinology and Journal of Bone and Mineral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact